Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resting Energy Expenditure in Palliative Cancer Patients (REPAT) - an Explorative Study in Patients With Incurable Cancer

NCT06206785 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resting Energy Expenditure in Palliative Cancer Patients (REPAT) - an Explorative Study in Patients With Incurable Cancer
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Active, not recruiting
Start date
September 5, 2023
Completion date
September 30, 2026
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, cancer